Bactrim and Klor-con m20 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bactrim (sulfamethoxazole; trimethoprim) and Klor-con m20 (potassium chloride). Common drug interactions include injection site pain among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Bactrim and Klor-con m20. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Bactrim?

Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.

What is Klor-con m20?

Klor-con m20 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 2,411 Klor-con m20 users. Check the latest studies of Klor-con m20.



On Jul, 08, 2026

65 people who take Bactrim and Klor-con m20 together, and have interactions are studied.

Bactrim and Klor-con m20 drug interactions.

What are the common drug interactions of Bactrim and Klor-Con M20, by gender? *:

female:

  1. Injection site pain
  2. Peripheral swelling
  3. Swollen tongue (swelling of tongue)
  4. Vitamin b12 deficiency
  5. Abdominal discomfort
  6. Abdominal wall abscess (abdominal wall infection)
  7. Acute respiratory failure
  8. Adverse drug reaction
  9. Adverse event
  10. Anaemia (lack of blood)

male:

  1. Fatigue (feeling of tiredness)
  2. Fall
  3. Device related infection
  4. Failure to thrive (inadequate weight gain and physical growth in children)
  5. Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
  6. Acute respiratory failure
  7. Anaemia (lack of blood)
  8. Arthralgia (joint pain)
  9. Ascites (accumulation of fluid in the abdominal cavity)
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the common drug interactions of Bactrim and Klor-Con M20, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)

30-39:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

40-49:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Cardiac failure congestive
  3. Chronic kidney disease
  4. Diarrhoea
  5. Emotional distress
  6. Hysterectomy
  7. Nausea (feeling of having an urge to vomit)
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Vomiting

50-59:

  1. Hospitalisation
  2. Blood cholesterol increased
  3. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  4. Jaw disorder (jaw disease)
  5. Surgery
  6. Weight increased

60+:

  1. Fatigue (feeling of tiredness)
  2. Decreased appetite
  3. White blood cell count decreased
  4. Abdominal pain
  5. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  6. Death
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Dehydration (dryness resulting from the removal of water)
  9. Device related infection
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 27 people, 41.54%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 12.31%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 12.31%
  4. Pain: 6 people, 9.23%
  5. High Blood Pressure: 5 people, 7.69%
  6. Nausea (feeling of having an urge to vomit): 4 people, 6.15%
  7. Drowsiness: 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Bactrim and Klor-con m20?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bactrim and Klor-con m20:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Klor-con m20:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klor-con m20 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and potassium chloride (the active ingredients of Bactrim and Klor-con m20, respectively), and Bactrim and Klor-con m20 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: